SK149198A3 - Feline vaccines containing chlamydia psittaci and method for making the same - Google Patents

Feline vaccines containing chlamydia psittaci and method for making the same Download PDF

Info

Publication number
SK149198A3
SK149198A3 SK1491-98A SK149198A SK149198A3 SK 149198 A3 SK149198 A3 SK 149198A3 SK 149198 A SK149198 A SK 149198A SK 149198 A3 SK149198 A3 SK 149198A3
Authority
SK
Slovakia
Prior art keywords
chlamydia psittaci
feline
vaccine
cats
cell line
Prior art date
Application number
SK1491-98A
Other languages
English (en)
Slovak (sk)
Inventor
Rebecca A Atherton
Norbert Schmeer
Jean A Hallstrom
Jennifer K Lane
Kristina J Hennessy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SK149198A3 publication Critical patent/SK149198A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/118Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/23Parvoviridae, e.g. feline panleukopenia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265Infectious rhinotracheitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1491-98A 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same SK149198A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,673 US5972350A (en) 1996-05-06 1996-05-06 Feline vaccines containing Chlamydia psittaci and method for making the same
PCT/US1997/007514 WO1997041889A1 (fr) 1996-05-06 1997-04-21 Vaccins pour felins contenant une chlamydia psittaci et leur procede de production

Publications (1)

Publication Number Publication Date
SK149198A3 true SK149198A3 (en) 2000-02-14

Family

ID=24581818

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1491-98A SK149198A3 (en) 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same

Country Status (16)

Country Link
US (1) US5972350A (fr)
EP (1) EP0904106A1 (fr)
JP (1) JP2000510121A (fr)
AU (1) AU717628B2 (fr)
BG (1) BG63564B1 (fr)
BR (1) BR9708975A (fr)
CA (1) CA2203234A1 (fr)
CZ (1) CZ297848B6 (fr)
EE (1) EE04516B1 (fr)
IL (1) IL126628A (fr)
NO (1) NO320871B1 (fr)
NZ (1) NZ332620A (fr)
PL (1) PL329734A1 (fr)
SK (1) SK149198A3 (fr)
TR (1) TR199802259T2 (fr)
WO (1) WO1997041889A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7105171B2 (en) * 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7306807B2 (en) * 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CN100423775C (zh) * 2005-04-15 2008-10-08 中国农业科学院兰州兽医研究所 牛衣原体病灭活疫苗及其制备与检验方法
KR20100038323A (ko) * 2007-05-30 2010-04-14 와이어쓰 엘엘씨 고양이 항원의 유전자를 발현하는 라쿤 폭스바이러스
FR3039406B1 (fr) 2015-07-28 2020-09-18 Centre Nat Rech Scient Composition vaccinale contre les infections a chlamydiaceae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
AU701247B2 (en) * 1993-11-03 1999-01-21 Pfizer Inc. Vaccine and method for treatment of chlamydial infections

Also Published As

Publication number Publication date
CZ297848B6 (cs) 2007-04-11
TR199802259T2 (xx) 1999-02-22
NO320871B1 (no) 2006-02-06
AU717628B2 (en) 2000-03-30
MX9703278A (es) 1998-05-31
EE9800388A (et) 1999-06-15
BG102890A (en) 1999-09-30
CA2203234A1 (fr) 1997-11-06
IL126628A0 (en) 1999-08-17
NO985172D0 (no) 1998-11-05
EP0904106A1 (fr) 1999-03-31
IL126628A (en) 2002-09-12
JP2000510121A (ja) 2000-08-08
BG63564B1 (bg) 2002-05-31
US5972350A (en) 1999-10-26
WO1997041889A1 (fr) 1997-11-13
NZ332620A (en) 2000-04-28
CZ360498A3 (cs) 1999-03-17
AU2996297A (en) 1997-11-26
EE04516B1 (et) 2005-08-15
PL329734A1 (en) 1999-04-12
BR9708975A (pt) 1999-08-03
NO985172L (no) 1999-01-06

Similar Documents

Publication Publication Date Title
JP3993230B2 (ja) 改良された修飾brsv生ワクチン
EP0329264B1 (fr) Vaccins vétérinaires
US5242686A (en) Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
CN109568573A (zh) 疫苗组合物及其制备方法和应用
US6951650B1 (en) Antigenic class of avian reoviruses
SK149198A3 (en) Feline vaccines containing chlamydia psittaci and method for making the same
KR100531491B1 (ko) 백신으로서 소 호흡 코로나바이러스
KR100302522B1 (ko) 고양이장코로나바이러스로부터의개코로나바이러스왁찐
EP0612532A2 (fr) Vaccin contre le coronavirus canin à partir de coronavirus entérique félin
US6004563A (en) Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US7211260B1 (en) Infectious bursitis vaccine
EP0310362B1 (fr) Vaccin pour la protection des chats contre la péritonite infectieuse féline
KR100556275B1 (ko) 클라미디아시타시를함유하는고양이백신및그의제조방법
US20020146425A1 (en) Feline vaccines containing chlamydia psittaci and method for making the same
MXPA97003278A (es) Vacunas felinas que contienen chlamydia psittaci y metodo para preparar las mismas
CN1223589A (zh) 包含鹦鹉热衣原体的猫疫苗及其制备方法
AU3441693A (en) Feline leukemia virus vaccines
FR2601251A1 (fr) Agent viral non pathogene pour la prevention de la gastroenterite transmissible porcine, son obtention et son utilisation comme vaccin.
MXPA99007134A (en) Infectious bursitis vaccine